Gotham Asset Management »

Cerevel Therapeutics Hldng I shares owned by Gotham Asset Management

Quarter-by-quarter ownership of Cerevel Therapeutics Hldng I (CERE) shares owned by Gotham Asset Management from 13F filings

Historical chart of Gotham Asset Management investment in Cerevel Therapeutics Hldng I

Tip: Access up to 7 years of quarterly data

All positions including Cerevel Therapeutics Hldng I held by Gotham Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cerevel Therapeutics Hldng I by Gotham Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $398k 9.4k 42.40

More positions owned by Gotham Asset Management

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Tidal Etf Tr Gotham Enhncd (GSPY)
Ishares Tr Core S&p500 Etf (IVV)
Apple (AAPL)
Snowflake Cl A (SNOW)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Tidal Etf Tr Gotham 1000 Valu (GVLU)
Amazon (AMZN)
Meta Platforms Cl A (META)
NVIDIA Corporation (NVDA)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Core Msci Emkt (IEMG)
Broadcom (AVGO)
Johnson & Johnson (JNJ)

View all positions for Gotham Asset Management

Top funds holding Cerevel Therapeutics Hldng I

Perceptive Advisors
venBio Select Advisor
Vanguard Group
Paradigm Biocapital Advisors
Balyasny Asset Management
Alpine Associates Management
Baker Bros. Advisors
Alliancebernstein
Millennium Management
Pentwater Capital Management
CNH Partners
Westchester Capital Management
Voloridge Investment Management
Westfield Capital Management Company
T. Rowe Price Associates

View all funds holding Cerevel Therapeutics Hldng I